Vertex Pharmaceuticals Research and Development Expenses 2010-2025 | VRTX
Vertex Pharmaceuticals research and development expenses for the twelve months ending March 31, 2025 were $3.821B, a 19.05% increase year-over-year.
- Vertex Pharmaceuticals annual research and development expenses for 2024 were $3.63B, a 14.78% increase from 2023.
- Vertex Pharmaceuticals annual research and development expenses for 2023 were $3.163B, a 24.51% increase from 2022.
- Vertex Pharmaceuticals annual research and development expenses for 2022 were $2.54B, a 31.09% increase from 2021.